Medicare Enrolled
Dr. Michael Levangie, MD
Cardiovascular Disease · Hyannis, MA
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Levangie from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Levangie?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Levangie
Dr. Michael Levangie is a cardiovascular disease specialist in Hyannis, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Levangie performed 7,256 Medicare services across 4,213 unique beneficiaries.
Between the years covered by Open Payments, Dr. Levangie received a total of $7,039 from 43 pharmaceutical and/or device companies across 369 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Levangie is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in MA
$7,039 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,256
Medicare services
Top 4% in MA for cardiovascular disease
4,213
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~382 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,839 | $11 | $43 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,719 | $91 | $182 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
549 | $6 | $20 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
440 | $41 | $60 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
368 | $63 | $142 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
338 | $149 | $540 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
327 | $8 | $16 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
203 | $16 | $33 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
185 | $50 | $203 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
179 | $349 | $1,200 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
173 | $50 | $69 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
147 | $21 | $42 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
144 | $135 | $242 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
95 | $29 | $54 |
| New patient office visit, complex (60-74 min) | 88 | $167 | $252 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
82 | $18 | $35 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
56 | $25 | $84 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
45 | $53 | $88 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
43 | $53 | $251 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
41 | $140 | $202 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
36 | $34 | $59 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
34 | $21 | $35 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
33 | $10 | $25 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
25 | $39 | $71 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
23 | $84 | $135 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
17 | $80 | $282 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
14 | $97 | $168 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
13 | $21 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.5% high complexity
13.5% medium
75.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,039
Total received (2018-2024)
Avg $1,006/year across 7 years
Top 28% in MA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
369
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,018 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$256
2023
$702
2022
$673
2021
$1,303
2020
$922
2019
$1,502
2018
$1,680
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$156
Boston Scientific Corporation
$61
E.R. Squibb & Sons, L.L.C.
$39
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$871
Abbott Laboratories
$819
Amgen Inc.
$617
Amarin Pharma Inc.
$532
Gilead Sciences, Inc.
$395
Janssen Pharmaceuticals, Inc
$380
SANOFI-AVENTIS U.S. LLC
$346
Esperion Therapeutics, Inc.
$341
Medtronic, Inc.
$223
AstraZeneca Pharmaceuticals LP
$221
Boston Scientific Corporation
$220
E.R. Squibb & Sons, L.L.C.
$212
AtriCure, Inc.
$203
Boehringer Ingelheim Pharmaceuticals, Inc.
$187
Medtronic Vascular, Inc.
$169
PFIZER INC.
$133
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$121
Regeneron Healthcare Solutions, Inc.
$120
BOSTON SCIENTIFIC CORPORATION
$104
Alnylam Pharmaceuticals Inc.
$76
Merck Sharp & Dohme Corporation
$70
Lundbeck LLC
$63
iRhythm Technologies, Inc.
$61
Edwards Lifesciences Corporation
$49
ARBOR PHARMACEUTICALS, INC.
$48
Daiichi Sankyo Inc.
$45
Astellas Pharma US Inc
$39
Otsuka America Pharmaceutical, Inc.
$38
Bayer HealthCare Pharmaceuticals Inc.
$35
Actelion Pharmaceuticals US, Inc.
$34
Novo Nordisk Inc
$34
Allergan Inc.
$33
GENZYME CORPORATION
$24
Kiniksa Pharmaceuticals, Ltd.
$23
Merck Sharp & Dohme LLC
$22
Kestra Medical Technology Services, Inc.
$19
CHF Solutions, Inc
$19
Vifor Pharma, Inc.
$18
Bardy Diagnostics, Inc.
$18
Amryt Pharma Holdings Ltd
$16
GE HEALTHCARE
$15
Arbor Pharmaceuticals, Inc.
$12
G Medical Diagnostic Services, Inc.
$12
Top 3 companies account for 32.8% of all-time payments
Associated products mentioned in payments ›
ATRICLIP LAA EXCLUSION SYSTEM · AZURE XT DR MRI SURESCAN · Anthem CRT Pacemaker · Aquadex · Arcalyst · Assure WCD · Assurity Pacemaker · Azure · BRILINTA · BYSTOLIC · CAMZYOS · COREVALVE EVOLUT R · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Claria MRI · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYS · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · FABRAZYME · HeartMate 3 Left Ventricular Dev · INJECTAFER · JARDIANCE · JUXTAPID · Kerendia · LEQVIO · LEXISCAN · LUX-Dx Insertable Cardiac Monitor · LifeVest · MULTAQ · Merlin Connectivity and Remote · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Percepta · Quadra Assura CRT Defibrillator · Quartet CRT Lead · Ranexa · Repatha · Rybelsus · SAMSCA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · WATCHMAN Access System · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
45
Per 100K population
19.6
County median income
$94,452
Nearest hospital
CAPE COD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Levangie is an electrophysiology & cardiac specialist, with above-average Medicare volume (top 4% in MA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Levangie experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Levangie performed 1,839 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Levangie receive payments from pharmaceutical companies?
Yes. Dr. Levangie received a total of $7,039 from 43 companies across 369 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Levangie's costs compare to other cardiologists in Hyannis?
Dr. Levangie's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Levangie) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Hyannis
Browse cardiologists in Hyannis ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MA
Which MA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology